subject area of
- A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder. Journal Articles
- Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective Journal Articles
- Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease Journal Articles
- Risk of Serious Falls Associated With Oxybutynin and Tolterodine: A Population Based Study Journal Articles